Jeremy Green
CIK 1650527 · last filed 2026-04-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$350.64M
Companies
27
Total Filings
117
Lifetime Open-Market Net
$526.02M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FATE | Director | 12,884,277 | $2.06 | $26.54M | $210.71M | 20 | 2026-04-23 |
| STTK | Director | 5,615,489 | $4.94 | $27.74M | $119.34M | 10 | 2025-08-26 |
| IGM Biosciences, Inc. (IGMS) Delisted | Director | 0 | $1.27 | $0 | $12.90M | 31 | 2025-08-15 |
| ADCT | 10%+ Owner | 28,762,443 | $1.05 | $30.20M | $8.41M | 4 | 2024-12-13 |
| Augmedix, Inc. (AUGX) Delisted | Director | 16,421,788 | $2.35 | $38.59M | $13.00M | 8 | 2024-06-18 |
| ABSI | Director | 8,262,136 | $6.80 | $56.18M | $62.00M | 4 | 2024-06-14 |
| Science 37 Holdings, Inc. (SNCE) Delisted | Director | 0 | $5.75 | $0 | $0 | 6 | 2024-03-13 |
| MedAvail Holdings, Inc. (MDVL) Delisted | Director | 53,702,312 | $1.80 | $96.66M | $0 | 2 | 2022-07-06 |
| Invivyd, Inc. (ADGI) Delisted | 10%+ Owner | 1,920,960 | $4.64 | $8.91M | $49.98M | 1 | 2021-08-12 |
| Verve Therapeutics, Inc. (VERV) Delisted | 10%+ Owner | 1,936,530 | $11.13 | $21.55M | $39.90M | 1 | 2021-06-23 |
| APRE | 10%+ Owner | 1,768,718 | $0.69 | $1.21M | -$5.58M | 1 | 2021-02-16 |
| KYMR | 10%+ Owner | 1,630,660 | $86.20 | $140.57M | $0 | 1 | 2020-08-25 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | 10%+ Owner | 823,371 | $9.81 | $8.08M | $0 | 1 | 2020-08-05 |
| ANNX | 10%+ Owner | 1,596,222 | $4.71 | $7.52M | $0 | 1 | 2020-07-30 |
| Repare Therapeutics Inc. (RPTX) Delisted | 10%+ Owner | 1,586,174 | $2.65 | $4.20M | $0 | 1 | 2020-06-25 |
| Neurogene Inc. (NLTX) Delisted | 10%+ Owner | 4,011,945 | $13.96 | $56.01M | $3.58M | 1 | 2020-04-06 |
| BEAM | 10%+ Owner | 1,161,458 | $29.03 | $33.72M | $0 | 1 | 2020-02-11 |
| Akero Therapeutics, Inc. (AKRO) Delisted | 10%+ Owner | 743,802 | $54.65 | $40.65M | $0 | 1 | 2019-06-24 |
| Atreca, Inc. (BCEL) Delisted | 10%+ Owner | 715,306 | $0.15 | $107.3K | $0 | 1 | 2019-06-24 |
| STOK | 10%+ Owner | 671,808 | $29.82 | $20.03M | $0 | 1 | 2019-06-24 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Director | 8,244,896 | — | — | $0 | 3 | 2019-05-24 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | 10%+ Owner | 807,256 | $1.48 | $1.19M | $0 | 1 | 2019-02-21 |
| VAPOTHERM INC (VAPO) Delisted | 10%+ Owner | 816,683 | $2.17 | $1.77M | $0 | 1 | 2018-11-16 |
| REPL | 10%+ Owner | 779,655 | $8.88 | $6.92M | $0 | 1 | 2018-07-25 |
| Allakos Inc. (ALLK) Delisted | 10%+ Owner | 1,009,090 | $0.33 | $332.1K | $0 | 1 | 2018-07-24 |
| SYRS | 10%+ Owner | 84,760 | $0.00 | $34 | $10.82M | 1 | 2016-07-07 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | 10%+ Owner | 12,956,446 | $14.49 | $187.74M | $954.7K | 1 | 2016-06-13 |
Recent Filings · Page 5 of 12
117 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-15 | Science 37 Holdings, Inc. (SNCE) Delisted | Grant (A) | +989,706 | $250.0K | EDGAR |
| 2023-05-04 | Augmedix, Inc. (AUGX) Delisted | Other (J) | −15,000,000 | -$45.00M | EDGAR |
| 2023-04-21 | FATE | Buy (P) | +553,278 | $3.41M | EDGAR |
| 2023-04-21 | Augmedix, Inc. (AUGX) Delisted | Grant (A) | +2,500,000 | $4.00M | EDGAR |
| 2023-04-17 | FATE | Mixed | −218,868 | -$3.22M | EDGAR |
| 2023-04-06 | IGM Biosciences, Inc. (IGMS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-04 | IGM Biosciences, Inc. (IGMS) Delisted | Grant (A) | +984 | $0 | EDGAR |
| 2023-01-04 | IGM Biosciences, Inc. (IGMS) Delisted | Grant (A) | +460 | $0 | EDGAR |
| 2022-10-18 | — | Buy (P) | +60,962 | $306.9K | |
| 2022-10-17 | — | Grant (A) | +60,962 | $306.9K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.